The Patent Finder
US

Methylphenidate-Prodrugs, Processes of Making and Using the Same

US 10,231,960 In force
OverviewFamilyAssignmentsSources & methods
Collateral for a security interest recorded Sep 11, 2026 (Truist Bank).

Term ends Jul 27, 2032 · High confidence

Filed Aug 26, 2016 as application 15/249,088 · Granted Mar 19, 2019
Base term, 20 years from filing
Today
20 years from filing
2012 2032
Clock starts
Jul 27, 2012
Term ends
Jul 27, 2032
Granted
Mar 19, 2019
base term fee events Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 9,079,928, to Jul 27, 2032. The term already ends on or before that date, so the cap shortened nothing.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jul 27, 2012, when application PCT/US2012/048641, the earliest non-provisional in its chain, was filed (this one was filed Aug 26, 2016)Jul 27, 2032High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 9,079,928)resolves to Jul 27, 2032, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderJul 27, 2032High confidence

This family

US 9,079,928In force
Jul 2032
Jul 2032
US 9,453,037In force
Jul 2032
Jul 2032
US 10,231,960this patent
Jul 2032
Jul 2032
Application 16/244,460Abandoned
not computed
not computed
4 of 5 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Nov 14, 2016
Reel 40312, frame 818
Guenther, Sven; Mickle, Travis; Chi, Guochen; Bera, Bindu; Bera, SanjibKempharm, Inc.Assignment of Assignor's Interest
Sep 5, 2018
Reel 47320, frame 697
Guenther, Sven; Chi, Guochen; Bera, Bindu; Mickle, Travis; Bera, SanjibKempharm, Inc.Corrective Assignment to Correct the Assignee's Address Previously Recorded at Reel: 040312 Frame: 0818. Assignor(S) Hereby Confirms the Assignment.
Oct 19, 2021
Reel 57848, frame 159
Guenther, Sven; Chi, Guochen; Bera, Bindu; Mickle, Travis; Bera, SanjibKempharm, Inc.Corrective Assignment to Correct the Assignee's Address on the Assignment Document Previously Recorded at Reel: 040312 Frame: 0818. Assignor(S) Hereby Confirms the Assignment .
Feb 26, 2024
Reel 66679, frame 668
Kempharm, Inc.Zevra Therapeutics, Inc.Change of Name
Apr 8, 2024
Reel 67040, frame 637
Zevra Therapeutics, Inc.Alter Domus (US) LLCSecurity Interest
Mar 13, 2026
Reel 75080, frame 907
Alter Domus (US) LLCZevra Therapeutics, Inc.Release of Security Interest
Mar 25, 2026
Reel 74186, frame 531
Zevra Therapeutics, Inc.Commave Therapeutics S.A.Assignment of Assignor's Interest
Mar 26, 2026
Reel 74194, frame 909
Zevra Therapeutics, Inc.Commave Therapeutics S.A.Assignment of Assignor's Interest
Sep 11, 2026
Reel 75980, frame 787
Commave Therapeutics S.A.Truist Bank, As Administrative AgentSecurity Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited